Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3949fd7e7bd63c20f62aaf8342240ba6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-14 |
filingDate |
2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebf93bf8005636f228452b23e101ec49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f6b399554ad6281c15be7355362862 |
publicationDate |
2013-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130007531-A |
titleOfInvention |
Methods, Devices, and Compositions for Intravitreal Injection |
abstract |
Disclosed are methods of treating ocular disorders. One or more substances are injected into the vitreous fluid of the eye using a syringe. The needle of the syringe is inserted into the eye so that the tip of the needle is below the stockpile. The needle of the syringe is inserted into the eye at the injection point located 3 mm to 5 mm behind the edge of the eye. The tip of the syringe is located at a depth of 1 mm to 10 mm from the eye's retina at the injection point. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220029106-A |
priorityDate |
2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |